chr7-94537790-A-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_022900.5(CASD1):āc.1162A>Gā(p.Asn388Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000341 in 1,613,024 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_022900.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
CASD1 | NM_022900.5 | c.1162A>G | p.Asn388Asp | missense_variant | 9/18 | ENST00000297273.9 | |
LOC105375404 | XR_007060433.1 | n.75-5812T>C | intron_variant, non_coding_transcript_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
CASD1 | ENST00000297273.9 | c.1162A>G | p.Asn388Asp | missense_variant | 9/18 | 1 | NM_022900.5 | P1 | |
SGCE | ENST00000645624.1 | n.834-13517T>C | intron_variant, non_coding_transcript_variant |
Frequencies
GnomAD3 genomes AF: 0.000178 AC: 27AN: 152106Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000638 AC: 16AN: 250612Hom.: 0 AF XY: 0.0000369 AC XY: 5AN XY: 135510
GnomAD4 exome AF: 0.0000199 AC: 29AN: 1460800Hom.: 0 Cov.: 30 AF XY: 0.0000206 AC XY: 15AN XY: 726750
GnomAD4 genome AF: 0.000171 AC: 26AN: 152224Hom.: 0 Cov.: 32 AF XY: 0.000161 AC XY: 12AN XY: 74416
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 14, 2021 | The c.1162A>G (p.N388D) alteration is located in exon 9 (coding exon 9) of the CASD1 gene. This alteration results from a A to G substitution at nucleotide position 1162, causing the asparagine (N) at amino acid position 388 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at